.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Julphar
Federal Trade Commission
Colorcon
Fish and Richardson
Harvard Business School
Daiichi Sankyo
Merck
UBS
Chinese Patent Office

Generated: December 16, 2017

DrugPatentWatch Database Preview

CENESTIN Drug Profile

« Back to Dashboard

When do Cenestin patents expire, and when can generic versions of Cenestin launch?

Cenestin is a drug marketed by Teva Branded Pharm and is included in one NDA.

The generic ingredient in CENESTIN is estrogens, conjugated synthetic a. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated synthetic a profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-001Jun 21, 2002DISCNYesNo► Subscribe► Subscribe► Subscribe
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-003Mar 24, 1999DISCNYesNo► Subscribe► Subscribe► Subscribe
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-005Feb 5, 2004DISCNYesNo► Subscribe► Subscribe► Subscribe
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-002Mar 24, 1999DISCNYesNo► Subscribe► Subscribe► Subscribe
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-004Mar 13, 2000DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CENESTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-001Jun 21, 2002► Subscribe► Subscribe
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-003Mar 24, 1999► Subscribe► Subscribe
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-004Mar 13, 2000► Subscribe► Subscribe
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-002Mar 24, 1999► Subscribe► Subscribe
Teva Branded PharmCENESTINestrogens, conjugated synthetic aTABLET;ORAL020992-005Feb 5, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for CENESTIN

Drugname Dosage Strength RLD Submissiondate
conjugated estrogen (synthetic a)Tablets0.3 mg, 0.45 mg and 0.9 mgCenestin3/19/2009
conjugated estrogen (synthetic a)Tablets0.625 mgCenestin3/2/2009
conjugated estrogen (synthetic a)Tablets1.25 mgCenestin11/3/2008

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
QuintilesIMS
Mallinckrodt
UBS
Novartis
Fuji
Fish and Richardson
Accenture
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot